Detail of the clinical trial

Title of the trial Randomized, open-label, parallel-group, multi-center phase II clinical trial of active cellular immunotherapy with preparation DCVAC/PCa in patients with localized high-risk prostate cancer after primary radiotherapy
EudraCT number 2011-004967-65
Protocol number SP004
Sponsor Sotio a.s., Jankovcova 1518/2, Praha 7 - Holešovice 170 00 ČR
Indications Oncology
Diagnosis prostate cancer
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 28.12.2011
Date of approval by EC 11.1.2012
Date of initiation CT in ČR 28.3.2012
Date of ending CT in ČR
Sites Ústav radiační onkologie 1. LF UK a FN na Bulovce, Budínova 2, Praha 8 180 81 ČR

‹‹ Back to list